EQUES Awarded Contract for AI Platform Verification Project for AMED
NQ Score
70/100
N1 Content Completeness
7
AI Summary (NQ-processed)
EQUES Co., Ltd., an AI startup from the University of Tokyo's Matsuo Lab, announced it has been awarded a contract and has begun a project for the Japan Agency for Medical Research and Development (AMED). The contract, won through a public tender, is for the "Trial Construction and Consulting Services for a Generative AI System for Drug Discovery Support." This trial project aims to improve operational efficiency and enhance Japan's drug discovery capabilities by leveraging AMED's accumulated drug discovery knowledge. The project will verify the applicability of generative AI, identify technical and operational challenges, and confirm compliance with security and governance standards.